Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$12.22 USD
+0.42 (3.56%)
Updated Apr 26, 2024 03:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
GTBIF 12.22 +0.42(3.56%)
Will GTBIF be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GTBIF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GTBIF
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
Green Thumb Industries Inc. (GTBIF) Misses Q4 Earnings Estimates
GTBIF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cannabis ETFs: What's Behind the Latest Surge
Strength Seen in Green Thumb Industries Inc. (GTBIF): Can Its 10.6% Jump Turn into More Strength?
Inside the Best-Performing ETF of Q3
Other News for GTBIF
Cannabis MSOs get date for oral arguments in federal marijuana law case
State-Run Vs. Private: Pennsylvania Debates Transition Of Liquor Store Model To Cannabis Distribution
Cannabis stocks outperform as pressure mounts on DEA to reschedule marijuana
Here's What You Missed in Cannabis, Psychedelics This Week
The Only 3 Cannabis Stocks Sensible Investors Are BuyingÂ